Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Mapping the genome of a fetus from its mother’s blood could mean less risky screening for prenatal diseases.
Drug companies are harnessing new knowledge of cancer genetics.
A startup is developing a new and potentially much cheaper sequencing technology based on microfluidics.
The select few who have had their genomes sequenced learn to use that information for health care.
Sequencing the genomes of both healthy and cancer cells from the same patient hints at how cancer metastasizes.